NeoGenomics (NEO) Peer Comparison

$16.28

$-0.87 (-5.07%)

As on 05-Nov-2026 14:34EST

Market cap

$2,249 Mln

Revenue (TTM)

$788 Mln

P/E Ratio

--

P/B Ratio

2.8

Div. Yield

0 %

Edit

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Market cap ($ Mln)	2,249	13,359	10,590	6,930	2,371
Revenue ($ Mln)	788	6,338	5,674	2,661	1,959
Net Profit ($ Mln)	-32.30	644.40	399.12	282.40	150.09
Net Margin (%)	-4.10	10.17	7.03	10.61	7.66
RoE (%)	-3.96	18.46	16.19	33.04	17.37
Price to Earnings	--	21.74	27.01	25.61	15.95
Price-To-Book	2.81	4.82	4.25	8.04	2.67

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Operating Revenue	787.75	6,338.10	5,674.31	2,661.04	1,959.12
Cost of Revenue	442.71	3,896.00	4,838.38	1,818.79	1,453.07
Gross Profit	282.54	2,564.90	799.45	758.34	471.88
Operating Expenses	392.14	1,280.70	326.77	471.57	282.68
Operating Profit (EBIT)	-47.09	1,161.40	509.16	370.86	223.38
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-36.18	1,065.80	532.53	382.32	203.43
Provision for Tax	-3.88	218.80	133.02	99.92	53.34
Profit after Tax (Net Income)	-32.30	644.40	399.12	282.40	150.09
Minority Interest	0.00	-164.20	-0.39	0.00	0.00
Consolidated Profit	0.00	145.70	0.00	76.75	33.68

Liabilities ($ Mln)

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Shareholder's Funds	800.64	2,681.20	2,559.31	861.42	849.62
Minority Interest	0.00	-164.20	-0.39	0.00	0.00
Non-Current Liabilities	460.11	3,077.90	2,472.09	526.08	754.07
Current Liabilities	116.17	927.40	962.91	330.93	535.73
Total Liabilities	1,359.83	7,089.70	5,462.97	1,640.01	2,246.70

Assets ($ Mln)

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Non-Current Assets	966.83	6,553.50	4,843.51	1,352.71	1,455.34
Current Assets	410.08	1,013.00	1,154.88	365.73	684.08
Total Assets	1,359.83	7,089.70	5,462.97	1,640.01	2,246.70
Total Debt*	449.14	2,803.40	2,287.65	392.19	612.00
Net Current Assets	293.91	0.00	191.97	0.00	148.35

Cashflow ($ Mln)

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Cash From Operating Activities	5.23	1,175.60	564.27	388.27	271.09
Cash Flow from Investing Activities	-12.34	-762.80	-513.18	-59.34	-18.30
Cash from Financing Activities	-200.29	-433.00	-11.81	-432.77	-107.49
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
ROCE (%)	-7.67	11.40	6.75	22.16	11.20
ROE (%)	-3.96	18.46	16.19	33.04	17.37
ROA (%)	-2.18	7.95	6.13	14.12	5.70
EBIT Margin (%)	-4.18	18.82	9.53	14.23	11.55
Net Margin (%)	-4.10	10.17	7.03	10.61	7.66
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Revenue Growth (%)	11.08	9.36	17.49	5.15	1.91
EBIT Growth (%)	70.01	16.63	22.99	1.29	-3.82
Net Profit Growth (%)	71.54	19.11	21.61	1.29	-7.46
EPS Growth (%)	71.79	21.08	20.07	10.23	-2.78
Book Value Growth (%)	-4.99	15.90	20.05	-11.47	2.43

Valuation Ratios

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Price / Earnings	-14.01	19.12	30.03	22.57	10.92
Price / Book Value	1.81	4.44	4.63	6.11	2.09
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-47.18	9.54	24.49	14.37	7.17
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Debt to Equity	0.47	0.00	0.08	0.00	0.47
Short term debt to equity ratio	0.01	0.03	0.05	0.05	0.22
Current Ratio	3.53	1.09	1.20	1.11	1.28
Quick Ratio	3.31	1.09	1.20	1.08	1.28
Interest Coverage	-10.15	9.39	66.70	78.72	7.11

Operating Efficiency Ratios

	NeoGenomics (NEO)	Encompass Health Corp (EHC)	The Ensign Group (ENSG)	Chemed Corp (CHE)	Mednax Inc (MD)
Debtors to sales (%)	27.09	11.23	11.72	9.58	12.27
Asset Turnover	0.53	0.78	0.87	1.33	0.74
Receivable days	77.78	37.48	43.58	25.53	49.13
Inventory Days	22.71	--	--	1.62	--
Payable days	18.35	18.92	8.42	10.06	10.59
Cash Conversion Cycle	82.14	--	--	17.10	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly